Volume : 11, Issue : 02, February – 2024
Title:
A REVIEW ARTICLE ON COMPUTER AIDED DRUG DESIGN (CADD)
Authors :
R. Laya, Dr. B. Aruna
Abstract :
Computer aided drug design CADD is an existing and diverse research merge and stimulate each other. Computer aided drug design CADD or in silico design in the application of computational or modelling in drug design. Various approaches to computer aided drug design are evaluated to show potential techniques in accordance with their needs. Two approaches are considered to designing of drug first one is structure-based and second one is ligand-based drug design. The recent foundations of CADD were established in the early 1970`s with the use of structural biological activity of insulin. The theoretical basis of CADD urges quantum mechanics and molecular modelling studies. It`s also based on the database searching and binding affinity on the basis of biological target. CADD biophysicists, structural biologists, prediction etc. These tools can tap in chemin formation to shorter the cycle of drug discovery, and thus made drug discovery most cost-effective. In this article, we can give an overview of the current computational drug design and their applications in the integrated rational drug development to aid in the progress of drug research.
KEY WORDS: Computer aided drug design, in silico design, molecular modelling, ligand, biological target, development process
Cite This Article:
Please cite this article in press R. Laya et al., Review Article On Computer Aided Drug Design (CADD), Indo Am. J. P. Sci, 2024; 11 (02).
Number of Downloads : 10
References:
1) C. M. Song, S. J. Lim, and J. C. Tong, “Recent advances in computer-aided drug design,” Briefings in Bioinformatics, vol. 10, no. 5, pp. 579–591, 2009.
2) J. A. DiMasi, H. G. Grabowski, and R. W. Hansen, “Innovation in the pharmaceutical industry: New estimates of R&D costs,” Journal of Health Economics, vol. 47, pp. 20–33, 2016.
3) D. Vohora and G. Singh, Pharmaceutical Medicine and Translational Clinical Research, Academic Press, 2018.
4) F. Zhong, J. Xing, X. Li et al., “Artificial intelligence in drug design,” Science China Life Sciences, vol. 61, no. 10, pp. 1191–1204, 2018.
5) T. Hou and X. Xu, “Recent development and application of virtual screening in drug discovery: an overview,” Current Pharmaceutical Design, vol. 10, no. 9, pp. 1011–1033, 2004.
6) W. Yu and A. D. Mac Kerell, “Computer-aided drug design methods,” in Antibiotics, Humana Press, New York, NY, 2017.
7) S. J. Y. Macalino, V. Gosu, S. Hong, and S. Choi, “Role of computer-aided drug design in modern drug discovery,” Archives of Pharmacal Research, vol. 38, no. 9, pp. 1686– 1701, 2015.
8) W. Duch, K. Swaminathan, and J. Meller, “Artificial intelligence approaches for rational drug design and discovery,” Current Pharmaceutical Design, vol. 13, no. 14, pp. 1497– 1508, 2007.
9) H.-J. Huang, H. W. Yu, C.-Y. Chen et al., “Current developments of computer-aided drug design,” Journal of the Taiwan Institute of Chemical Engineers, vol. 41, no. 6, pp. 623–635, 2010.
10) M. Hassan Baig, K. Ahmad, S. Roy et al., “Computer aided drug design: success and limitations,” Current Pharmaceutical Design, vol. 22, no. 5, pp. 572–581, 2016.
11) S. Skariyachan, S. B. Challapilli, S. Packirisamy, S. T. Kumargowda, and V. S. Sridhar, “Recent aspects on the pathogenesis mechanism, animal models and novel therapeutic interventions for Middle East respiratory syndrome coronavirus infections,” Frontiers in Microbiology, vol. 10, p. 569, 2019.
12) S. A. Amin and T. Jha, “Fight against novel coronavirus: a perspective of medicinal chemists,” European Journal of Medicinal Chemistry, vol. 201, article 112559, 2020.
13) B. Goyal and D. Goyal, “Targeting the dimerization of the main protease of coronaviruses: A potential broad-spectrum therapeutic strategy,” ACS Combinatorial Science, vol. 22, no. 6, pp. 297–305, 2020.
14) W. Dai, B. Zhang, X.-M. Jiang et al., “Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease,” Science, vol. 368, no. 6497, pp. 1331–1335, 2020.
15) Y.-F. Tu, C.-S. Chien, A. A. Yarmishyn et al., “A review of SARS-CoV-2 and the ongoing clinical trials,” International Journal of Molecular Sciences, vol. 21, no. 7, p. 2657, 2020.
16) D. Gopal and S. Skariyachan, Recent Perspectives on COVID19 and Computer-Aided Virtual Screening of Natural Compounds for the Development of Therapeutic Agents Towards SARS-CoV-2, Methods in Pharmacology and Toxicology, Springer, 2020.
17) T. Pillaiyar, S. Meenakshisundaram, and M. Manickam, “Recent discovery and development of inhibitors targeting coronaviruses,” Drug Discovery Today, vol. 25, no. 4, pp. 668–688, 2020.
18) M. Batool, B. Ahmad, and S. Choi, “A structure-based drug discovery paradigm,” International Journal of Molecular Sciences, vol. 20, no. 11, p. 2783, 2019.
19) E. Lionta, G. Spyrou, D. K. Vassilatis, and Z. Cournia, “Structure-based virtual screening for drug discovery: principles, applications and recent advances,” Current Topics in Medicinal Chemistry, vol. 14, no. 16, pp. 1923–1938, 2014.
20) S. Kalyaanamoorthy and Y.-P. P. Chen, “Structure-based drug design to augment hit discovery,” Drug Discovery Today, vol. 16, no. 17–18, pp. 831–839, 2011.
21) A. Wlodawer and J. Vondrasek, “Inhibitors of HIV-1 protease: a major success of structure-assisted drug design,” Annual Review of Biophysics and Biomolecular Structure, vol. 27, no. 1, pp. 249–284, 1998.
22) D. E. Clark, “What has computer-aided molecular design ever done for drug discovery?,” Expert Opinion on Drug Discovery, vol. 1, no. 2, pp. 103–110, 2006.
23) A. C. Anderson, “The process of structure-based drug design,” Chemistry & Biology, vol. 10, no. 9, pp. 787–797, 2003.
24) S. Grover, M. A. Apushkin, and G. A. Fishman, “Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa,” American Journal of Ophthalmology, vol. 141, no. 5, pp. 850–858, 2006.
25) H. Marrakchi, G. Lanéelle, and A. Quémard, “InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II,” Microbiology, vol. 146, no. 2, pp. 289–296, 2000.
26) S. Dadashpour, T. Tuylu Kucukkilinc, O. Unsal Tan, K. Ozadali, H. Irannejad, and S. Emami, “Design, synthesis and in vitro study of 5, 6-dDiaryl-1, 2, 4-triazine-3-ylthioacetate derivatives as COX-2 and β-amyloid aggregation inhibitors,” Archiv der Pharmazie, vol. 348, no. 3, pp. 179–187, 2015.
27) Z. Miller, K.-S. Kim, D.-M. Lee et al., “Proteasome inhibitors with pyrazole scaffolds from structure-based virtual screening,” Journal of Medicinal Chemistry, vol. 58, no. 4, pp. 2036–2041, 2015.
28) X. Wang, K. Song, L. Li, and L. Chen, “Structure-based drug design strategies and challenges,” Current Topics in Medicinal Chemistry, vol. 18, no. 12, pp. 998–1006, 2018. [29] V. K. Vyas, R. D. Ukawala, C. Chintha, and M. Ghate, “Homology modelling a fast tool for drug discovery: current perspectives,” Indian Journal of Pharmaceutical Sciences, vol. 74, no. 1, pp. 1–17, 2012.
29) C. M.-R. Lemer, M. J. Rooman, and S. J. Wodak, “Protein structure prediction by threading methods: evaluation of current techniques,” Proteins: Structure, Function, and Genetics, vol. 23, no. 3, pp. 337–355, 1995.
30) J. Lee, P. L. Freddolino, and Y. Zhang, “Ab initio protein structure prediction,” in From protein structure to function with bioinformatics, Springer, 2017.
31) M. T. Muhammed and E. Aki-Yalcin, “Homology modeling in drug discovery: Overview, current applications, and future perspectives,” Chemical Biology & Drug Design, vol. 93, no. 1, pp. 12–20, 2019.
32) J. Xu, F. Jiao, and L. Yu, “Protein structure prediction using threading,” in Protein structure prediction, Springer, 2008.
33) M. Yousef, T. Abdelkader, and K. El-Bahnasy, “Performance comparison of ab initio protein structure prediction methods,” Ain Shams Engineering Journal, vol. 10, no. 4, pp. 713–719, 2019.
34) L. Pan, C. L. Gardner, F. A. Pagliai, C. F. Gonzalez, and G. L. Lorca, “Identification of the tolfenamic acid binding pocket in PrbP from Liberibacter asiaticus,” Frontiers in Microbiology, vol. 8, 2017
35) T. A. Binkowski, S. Naghibzadeh, and J. Liang, “CASTp: computed atlas of surface topography of proteins,” Nucleic Acids Research, vol. 31, no. 13, pp. 3352–3355, 20